Cortney Caudill insider trades

Open-market stock purchases and sales by Cortney Caudill, SVP, CHIEF OPERATING OFFICER at Halozyme Therapeutics, Inc, from SEC Form 4 filings since Oct 3, 2025.

Recent trades

DateStockTradeValue
Mar 10, 2026HALO Halozyme Therapeutics, IncSold$599K
Mar 10, 2026HALO Halozyme Therapeutics, IncBought (not open market)$51.8K
Mar 9, 2026HALO Halozyme Therapeutics, IncSold$1.2M
Mar 9, 2026HALO Halozyme Therapeutics, IncSold$143K
Mar 9, 2026HALO Halozyme Therapeutics, IncBought (not open market)$670K
Feb 20, 2026HALO Halozyme Therapeutics, IncSold (not open market)$73.6K
Feb 20, 2026HALO Halozyme Therapeutics, IncBought (not open market)—
Feb 9, 2026HALO Halozyme Therapeutics, IncBought (not open market)—
Feb 9, 2026HALO Halozyme Therapeutics, IncBought (not open market)—
Feb 9, 2026HALO Halozyme Therapeutics, IncBought (not open market)—
Feb 9, 2026HALO Halozyme Therapeutics, IncBought (not open market)—
Nov 1, 2025HALO Halozyme Therapeutics, IncBought (not open market)—
Nov 1, 2025HALO Halozyme Therapeutics, IncSold$278K
Oct 3, 2025HALO Halozyme Therapeutics, IncBought (not open market)—
Oct 3, 2025HALO Halozyme Therapeutics, IncBought (not open market)—

Companies traded

  • HALO Halozyme Therapeutics, Inc: 4 sales, last Mar 10, 2026

Get free alerts when Cortney Caudill files a new trade →